Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

PTPI Stock Annual Income Statement. Download in Excel

Petros Pharmaceuticals Inc logo

Petros Pharmaceuticals Inc

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

0.33
 
USD
  
0.00
  
(-0.92%)
Previous close: 0.3376  Open: 0.3275  Bid: 0.3102  Ask: 0.348
52 week range    
0.22   
   2.27
Mkt Cap: 3 M  Avg Vol (90 Days): 204,769
Peers   
NWBO / 
NYMX / 
OHCS / 
Last updated: Friday 6th December 2024

Stock Rankings

62
MarketXLS Rank
80
Value
69
Technical
39
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

PTPI Income Statement

Annual
Invalid dateDec-21Dec-22Dec-23
AccretionOnPreferredStock5 M
AccruedPreferredStockDividends821456.0
Amortization of intangibles25 M12 M9 M
Basic EPS from continuing operations-8.25-9.68-6.35
Basic EPS total-8.25-9.68-6.35
Basic weighted shares outstanding1 M2 M2 M
Cost of sales2 M2 M2 M
Depreciation7 M6 M3 M
Depreciation unreconciled7 M6 M3 M
DepreciationAndAmortization7 M6 M3 M
Diluted EPS total-8.25-9.68-6.35
Diluted normalized net income/share-8.25-9.68-6.35
Diluted weighted shares outstanding1 M2 M2 M
GainOnSaleOfSecurity9 M460000.03 M
GeneralAndAdministrativeExpense16 M12 M9 M
Gross operating profit6 M4 M4 M
ImpairmentOfCapitalAssets7 M
Income before tax-9 M-20 M-8 M
Interest income14194.0
InterestExpenseNonOperating368660.0-14194.0-515311.0
InterestExpenseOperating356160.0
InterestIncomeOperating14194.0515311.0
MiscOtherSpecialCharges14 M
Net income from total operations-9 M-20 M-8 M
NetIncomeCommonStockholders-9 M-20 M-14 M
NetIncomeContinuousOperations-9 M-20 M-8 M
NetIncomeFromOtherGainsLosses-368660.0
NetNonOperatingInterestIncomeExpense-368660.014194.0515311.0
NonRecurringOperationExpense-3 M
Operating income-18 M-20 M-14 M
Operating income before depreciation (EBITDA)-1 M-14 M-5 M
OperatingExpense24 M20 M18 M
Other income net-9 M-4 M-17 M
OtherGandA16 M12 M9 M
OtherImpairmentOfCapitalAssets7 M
OtherOperatingExpenses179246.0179246.0179246.0
OtherunderPreferredStockDividend6 M
PreferredStockDividends6 M
Research & development expense2 M2 M2 M
ResearchExpense2 M2 M2 M
Revenue per share25 M12 M9 M
SalariesAndWages1 M
Selling Gen & administrative expense16 M12 M9 M
Special income/charges-4 M
Total Income available for interest expense (EBIT)-8 M-20 M-9 M
Total common shares outstanding21 M2 M7 M
Total net income-9 M-20 M-8 M
Total ordinary shares10 M10 M10 M
Total revenues8 M6 M6 M
TotalExpenses26 M22 M19 M
TotalRevenue8 M6 M6 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University